
Sign up to save your podcasts
Or


"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
376376 ratings
"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.
See omnystudio.com/listener for privacy information.

1,720 Listeners

970 Listeners

404 Listeners

1,170 Listeners

2,201 Listeners

969 Listeners

675 Listeners

198 Listeners

1,038 Listeners

1,302 Listeners

62 Listeners

30 Listeners

59 Listeners

5 Listeners

58 Listeners

233 Listeners

234 Listeners

63 Listeners

85 Listeners

80 Listeners

76 Listeners

86 Listeners

403 Listeners

8 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

22 Listeners